Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-(2-(phosphonomethoxy)ethyl)adenine Diphosphate
2. Pmeapp
1. Pmeapp
2. Adefovir Diphosphate
3. 129532-77-0
4. Pmea-dp
5. 9-(meoet)-a-tp
6. 9-(2-(phosphonomethoxy)ethyl)adenine Diphosphate
7. 2-(6-aminopurin-9-yl)ethoxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic Acid
8. N-(2-diphosphorylphosphonylmethoxyethyl)-adenine
9. Diphosphoric Acid, Monoanhydride With ((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)phosphonic Acid
10. Diphosphoric Acid, Monoanhydride With [[2-(6-amino-9h-purin-9-yl)ethoxy]methyl]phosphonic Acid
11. Pmea-pp
12. 1pk0
13. 9-(2-phosphonylmethoxyethyl)adenine Diphosphate
14. Chembl1162433
15. Schembl13394184
16. Dtxsid60156198
17. Bdbm50479983
18. Q27459979
19. [2-(6-amino-9h-purine-9-yl)ethoxy]methylphosphonyldiphosphate
20. 2-(6-aminopurin-9-yl)ethoxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxy-phosphinic Acid
| Molecular Weight | 433.15 g/mol |
|---|---|
| Molecular Formula | C8H14N5O10P3 |
| XLogP3 | -4.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 9 |
| Exact Mass | 432.99535265 g/mol |
| Monoisotopic Mass | 432.99535265 g/mol |
| Topological Polar Surface Area | 229 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 632 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Adefovir Diphosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Adefovir Diphosphate, including repackagers and relabelers. The FDA regulates Adefovir Diphosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Adefovir Diphosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Adefovir Diphosphate supplier is an individual or a company that provides Adefovir Diphosphate active pharmaceutical ingredient (API) or Adefovir Diphosphate finished formulations upon request. The Adefovir Diphosphate suppliers may include Adefovir Diphosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Adefovir Diphosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Adefovir Diphosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Adefovir Diphosphate active pharmaceutical ingredient (API) in detail. Different forms of Adefovir Diphosphate DMFs exist exist since differing nations have different regulations, such as Adefovir Diphosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Adefovir Diphosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Adefovir Diphosphate USDMF includes data on Adefovir Diphosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Adefovir Diphosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Adefovir Diphosphate suppliers with USDMF on PharmaCompass.
Adefovir Diphosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Adefovir Diphosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Adefovir Diphosphate GMP manufacturer or Adefovir Diphosphate GMP API supplier for your needs.
A Adefovir Diphosphate CoA (Certificate of Analysis) is a formal document that attests to Adefovir Diphosphate's compliance with Adefovir Diphosphate specifications and serves as a tool for batch-level quality control.
Adefovir Diphosphate CoA mostly includes findings from lab analyses of a specific batch. For each Adefovir Diphosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Adefovir Diphosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Adefovir Diphosphate EP), Adefovir Diphosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Adefovir Diphosphate USP).
LOOKING FOR A SUPPLIER?
